Eckardt K-U, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, et al. Evolving importance of kidney disease: from subspecialty to global health burden. The Lancet. 2013;382(9887):158–69.

Article  Google Scholar 

Schaub JA, Hamidi H, Subramanian L, Kretzler M. Systems biology and kidney disease. Clin J Am Soc Nephrol. 2020;15(5):695–703.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao Y, Shi Y, Shen H, Xie W. m(6)A-binding proteins: the emerging crucial performers in epigenetics. J Hematol Oncol. 2020;13(1):35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ding H, Zhang L, Yang Q, Zhang X, Li X. Epigenetics in kidney diseases. Adv Clin Chem. 2021;104:233–97.

Article  CAS  PubMed  Google Scholar 

Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3’ UTRs and near stop codons. Cell. 2012;149(7):1635–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duan HC, Wang Y, Jia G. Dynamic and reversible RNA N(6) -methyladenosine methylation. Wiley Interdiscip Rev RNA. 2019;10(1):e1507.

Article  PubMed  Google Scholar 

Covelo-Molares H, Bartosovic M, Vanacova S. RNA methylation in nuclear pre-mRNA processing. Wiley Interdiscip Rev RNA. 2018;9(6):e1489.

Article  PubMed  PubMed Central  Google Scholar 

Linder B, Grozhik AV, Olarerin-George AO, Meydan C, Mason CE, Jaffrey SR. Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat Methods. 2015;12(8):767–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu ZX, Li LM, Sun HL, Liu SM. Link between m6A modification and cancers. Front Bioeng Biotechnol. 2018;6:89.

Article  PubMed  PubMed Central  Google Scholar 

Peng Z, Gong Y, Wang X, He W, Wu L, Zhang L, et al. METTL3-m(6)A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease. Mol Ther. 2022;30(2):932–46.

Article  CAS  PubMed  Google Scholar 

Nie K, Yi J, Yang Y, Deng M, Yang Y, Wang T, et al. A broad m6A modification landscape in inflammatory bowel disease. Front Cell Dev Biol. 2021;9:782636.

Article  PubMed  Google Scholar 

Huang W, Chen TQ, Fang K, Zeng ZC, Ye H, Chen YQ. N6-methyladenosine methyltransferases: functions, regulation, and clinical potential. J Hematol Oncol. 2021;14(1):117.

Article  PubMed  PubMed Central  Google Scholar 

Wu B, Li L, Huang Y, Ma J, Min J. Readers, writers and erasers of N(6)-methylated adenosine modification. Curr Opin Struct Biol. 2017;47:67–76.

Article  PubMed  Google Scholar 

Yue Y, Liu J, He C. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev. 2015;29(13):1343–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lence T, Paolantoni C, Worpenberg L, Roignant JY. Mechanistic insights into m(6)A RNA enzymes. Biochim Biophys Acta Gene Regul Mech. 2019;1862(3):222–9.

Article  CAS  PubMed  Google Scholar 

Qi S, Mota J, Chan SH, Villarreal J, Dai N, Arya S, et al. RNA binding to human METTL3-METTL14 restricts N(6)-deoxyadenosine methylation of DNA in vitro. Elife. 2022;11:e67150.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scholler E, Weichmann F, Treiber T, Ringle S, Treiber N, Flatley A, et al. Interactions, localization, and phosphorylation of the m(6)A generating METTL3-METTL14-WTAP complex. RNA. 2018;24(4):499–512.

Article  PubMed  PubMed Central  Google Scholar 

Wang P, Doxtader KA, Nam Y. Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol Cell. 2016;63(2):306–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang J, Dong X, Gong Z, Qin LY, Yang S, Zhu YL, et al. Solution structure of the RNA recognition domain of METTL3-METTL14 N(6)-methyladenosine methyltransferase. Protein Cell. 2019;10(4):272–84.

Article  CAS  PubMed  Google Scholar 

Meiser N, Mench N, Hengesbach M. RNA secondary structure dependence in METTL3-METTL14 mRNA methylation is modulated by the N-terminal domain of METTL3. Biol Chem. 2020;402(1):89–98.

Article  PubMed  Google Scholar 

Wang X, Feng J, Xue Y, Guan Z, Zhang D, Liu Z, et al. Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex. Nature. 2016;534(7608):575–8.

Article  CAS  PubMed  Google Scholar 

Huang Q, Mo J, Liao Z, Chen X, Zhang B. The RNA m(6)A writer WTAP in diseases: structure, roles, and mechanisms. Cell Death Dis. 2022;13(10):852.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yue Y, Liu J, Cui X, Cao J, Luo G, Zhang Z, et al. VIRMA mediates preferential m(6)A mRNA methylation in 3’UTR and near stop codon and associates with alternative polyadenylation. Cell Discov. 2018;4:10.

Article  PubMed  PubMed Central  Google Scholar 

Dai XY, Shi L, Li Z, Yang HY, Wei JF, Ding Q. Main N6-methyladenosine readers: YTH family proteins in cancers. Front Oncol. 2021;11:635329.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ru W, Zhang X, Yue B, Qi A, Shen X, Huang Y, et al. Insight into m(6)A methylation from occurrence to functions. Open Biol. 2020;10(9):200091.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang Z, Mei W, Qu C, Lu J, Shang L, Cao F, et al. Role of m6A writers, erasers and readers in cancer. Exp Hematol Oncol. 2022;11(1):45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi H, Wei J, He C. Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol Cell. 2019;74(4):640–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu N, Dai Q, Zheng G, He C, Parisien M, Pan T. N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions. Nature. 2015;518(7540):560–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou KI, Shi H, Lyu R, Wylder AC, Matuszek Z, Pan JN, et al. Regulation of co-transcriptional pre-mRNA Splicing by m(6)A through the low-complexity protein hnRNPG. Mol Cell. 2019;76(1):70–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alarcon CR, Goodarzi H, Lee H, Liu X, Tavazoie S, Tavazoie SF. HNRNPA2B1 Is a mediator of m(6)A-dependent nuclear RNA processing events. Cell. 2015;162(6):1299–308.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meyer KD, Jaffrey SR. The dynamic epitranscriptome: N6-methyladenosine and gene expression control. Nat Rev Mol Cell Biol. 2014;15(5):313–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chowen JA, Vujovic P, Stamenkovic S, Jasnic N, Lakic I, Djurasevic SF, et al. Fasting induced cytoplasmic Fto expression in some neurons of rat hypothalamus. PLoS ONE. 2013;8(5):e63694.

Article  Google Scholar 

Cheung MK, Gulati P, O’Rahilly S, Yeo GSH. FTO expression is regulated by availability of essential amino acids. Int J Obes. 2012;37(5):744–7.

Article  Google Scholar 

Obrador GT, Levin A. CKD hotspots: challenges and areas of opportunity. Semin Nephrol. 2019;39(3):308–14.

Article  PubMed  Google Scholar 

Wang Z, Zhang C. From AKI to CKD: maladaptive repair and the underlying mechanisms. Int J Mol Sci. 2022;23(18):10572.

Article  PubMed  PubMed Central  Google Scholar 

Jiang L, Liu X, Hu X, Gao L, Zeng H, Wang X, et al. METTL3-mediated m(6)A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy. Mol Ther. 2022;30(4):1721–40.

Article  CAS  PubMed  PubMed Central